Skip Navigation

Strengthening the evidence for maternal and child health programs

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.


Displaying records 1 through 20 (43 total).

Barzel R, Holt K. 2019. Opioids and children and adolescents: Information for oral health professionals. Washington, DC: National Maternal and Child Oral Health Resource Center, 6 pp.

Annotation: This document provides guidance on opioids for oral health professionals. It includes information about assessing children and adolescents, drugs to recommend before prescribing opioids, prescribing opioids with caution and being aware of the potential for misuse or abuse, and understanding laws, policies, and recommendations. The document also discusses providing post-operative instructions and creating a safe, friendly environment. Information about prescription-drug-monitoring programs and managing acute oral pain are included, along with tips for dentists to share with parents and an overview of research. [Funded by the Maternal and Child Health Bureau]

Contact: National Maternal and Child Oral Health Resource Center, Telephone: (202) 784-9771 E-mail: OHRCinfo@georgetown.edu Web Site: https://www.mchoralhealth.org Available from the website.

Keywords: Adolescent health, Child health, Drug abuse, Narcotics, Oral health, Pain, Prescription drugs, Prevention

American Dental Association Health Policy Institute. 2018. Opioid prescribing by dentists. American Dental Association Health Policy Institute, 1 p.

Annotation: This infographic provides information about trends in the percentages of opioids prescribed by dentists to individuals with private dental insurance between 2010 and 2015. Total percentages are provided, as well as percentages by age group. Information about days’ supply and quantities of pills prescribed by dentists to individuals with private insurance for 2010–2015 is also presented.

Contact: American Dental Association, Health Policy Institute, 211 East Chicago Avenue, Chicago, IL 60611-2678, Telephone: (312) 440-2500 Web Site: http://www.ada.org/en/science-research/health-policy-institute

Keywords: , Narcotics, Oral health, Oral health care, Prescription Drugs, Statistical data, Trends

Oregon Pregnancy and Opioids Workgroup. 2018. Oregon Pregnancy and Opioids Workgroup recommendations. Salem, OR: Oregon Health Authority, Public Health Division, 27 pp.

Annotation: This document provides recommendations for the management of opioid use for pregnant women, including pregnant women with opioid-use disorder, and for care of the opioid-exposed newborn. Topics include clinical recommendations, health-systems and policy recommendations, definitions, and resources and collaborative approaches.

Contact: Oregon Health Authority, 500 Summer Street, N.E., E-20, Salem, OR 97301-1097, Telephone: (503) 947-2340 Secondary Telephone: (877) 398-9238 Fax: (503) 947-2341 E-mail: OHPBinfo@state.or.us Web Site: http://www.oregon.gov/oha Available from the website.

Keywords: Narcotics, Oral health, Oregon, Pregnant women, Prescription drugs, State programs, Substance abuse, Substance dependence

Barzel R, Holt K, Kolo S. 2018. Prescribing opioids for women of reproductive age: Information for dentists. Washington, DC: National Maternal and Child Oral Health Resource Center, 4 pp.

Annotation: This practice guidance provides an overview of pain management for dental procedures for women of reproductive age. It discusses pharmacological considerations for pregnant women (pharmaceutical agents and indications, contraindications, and special considerations), neonatal opioid withdrawal syndrome, guidelines for providing opioids, managing acute dental pain, and guidelines for discharging women with opioid prescriptions. Information about prescription drug monitoring programs is included. [Funded by the Maternal and Child Health Bureau]

Contact: National Maternal and Child Oral Health Resource Center, Telephone: (202) 784-9771 E-mail: OHRCinfo@georgetown.edu Web Site: https://www.mchoralhealth.org Available from the website.

Keywords: , Drug addiction, Guidelines, Narcotics, Neonatal abstinence syndrome, Oral health, Pain relieving drugs, Pregnant women, Prescription drugs

Clevenger AA. 2017. Overdose poisoning deaths to children in Virginia, 2009-2013. Richmond, VA: Virginia Department of Health, Office of the Chief Medical Examiner, 57 pp.

Annotation: This report presents findings, conclusions, and recommendations from case reviews of overdose poison deaths among infants, children, and adolescents up to age 17 in Virginia for the five year period between 2009 and 2013. Topics include how overdose is impacting infants and children and their families in Virginia, which children are at risk, where are they at risk, how are they at risk, and what can be done to further promote health and safety in their lives. [Funded in part by the Maternal and Child Health Bureau]

Contact: Virginia Department of Health, Office of the Chief Medical Examiner, 400 East Jackson Street, Richmond, VA 23219, Telephone: (804) 786-3174 Fax: (804) 371-8595 E-mail: OCME_CENT@vdh.virginia.gov Web Site: http://www.vdh.virginia.gov/medical-examiner Available from the website.

Keywords: Adolescents, Case studies, Child death review, Child safety, Children, Health promotion, High risk groups, Household safety, Infants, Injury prevention, Opiates, Poisoning, Prescription drugs, Virginia

Illinois Department of Public Health. 2017. Antiobiotic stewardship toolkit for dental providers. Sringfield, IL: Illinois Department of Public Health, 33 pp.

Annotation: This toolkit provides dentists with resources to support judicious use of antibiotics in outpatient settings as part of the Illinois Precious Drugs & Scary Bugs Campaign. The toolkit is organized around four core elements set forth by the Centers for Disease Control and Prevention: commitment, action for policy and practice, tracking and reporting, and education and expertise.

Contact: Illinois Department of Public Health, Division of Oral Health, 535 West Jefferson Street, Third Floor, Springfield, IL 62761, Telephone: (217) 785-4899 Secondary Telephone: (800) 547-0466 Fax: (217) 524-4201 Web Site: http://www.dph.illinois.gov/topics-services/prevention-wellness/oral-health

Keywords: Antibiotics, Illinois, Oral health, Prescription drugs, Public awareness campaigns, Dentists, State programs

Oregon Health Authority, Oral Health Unit. 2017. Opioid prescribing guidelines for dentists. Portland, OR: Oregon Health Authority, Oral Health Unit, 1 p.

Annotation: This document for dentists provides guidelines on prescribing opioids. Appropriate dosages, types of medication to prescribe, prescribing refills, using guidelines for pain management, and ensuring that patients know how to secure medication and dispose of leftover medication are discussed. Alternatives to prescribing opioids are presented. Information is included on how to obtain the document in large print, Braille, non- English languages, or other formats.

Contact: Oregon Health Authority, Oral Health Program, 800 N.E. Oregon Street, Suite 850, Portland, OR 97232, Telephone: (971) 673-0348 Secondary Telephone: (971) 673-0372 Fax: (971) 673-0240 E-mail: oral.health@state.or.us Web Site: https://public.health.oregon.gov/PreventionWellness/oralhealth/Pages/index.aspx

Keywords: Guidelines, Medications, Opiates, Pain, Non English language materials, Prescription drugs

Children's Safety Network. 2016. Medication abuse prevention: 2016 resource guide. Waltham, MA: Children's Safety Network, 19 pp.

Annotation: This guide describes organizations, policy and legislation, prevention programs, publications, and webinars focused on prescription drug overdose prevention among youth and young adults. Contents include descriptions of reports, guides, toolkits, campaigns, website, iinitiatives, and research studies. Each item includes a short description and a link to the resource itself. Information about child safety and neonatal abstinence syndrome are included. [Funded by the Maternal and Child Health Bureau]

Contact: Children's Safety Network, Education Development Center, 43 Foundry Avenue, Waltham, MA 02453-8313, Telephone: (617) 618-2918 Fax: (617) 969-9186 E-mail: csninfo@edc.org Web Site: http://www.childrenssafetynetwork.org Available from the website.

Keywords: Adolescents, Children, Drug effects, Infants, Legislation, Multimedia, Neonatal abstinence syndrome, Policy development, Prescription drugs, Resource materials, Resources for professionals, Safety, Substance abuse prevention, Substance abuse prevention programs, Young adults

Rudd RA, Seth P, Felicita D, Scholl L. 2016. Increases in drug and opioid-involved overdose deaths: United States, 2010–2015. Morbidity and Mortality Weekly Report 65(50–51):1445–1452,

Annotation: This report examines overall drug overdose death rates during 2010-2015 and opioid overdose death rates during 2014–2015 by subcategories (natural/semisynthetic opioids, methadone, heroin, and synthetic opioids other than methadone). Rates are stratified by demographics, region, and by 28 states with high quality reporting on death certificates of specific drugs involved in overdose deaths. Implications for public health practice are included.

Contact: Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 E-mail: cdcinfo@cdc.gov Web Site: http://www.cdc.gov Available from the website.

Keywords: Chronic pain, Collaboration, Drug addiction, Heroin, Illicit drugs, Methadone, Mortality rates, Opiates, Prescription drugs, Substance abuse prevention, Substance abuse treatment services

U.S. Preventive Services Task Force. 2014. Drug use, illicit: Primary care interventions for children and adolescents. Rockville, MD: U.S. Preventive Services Task Force, multiple items.

Medicine Abuse Project. [2013]. "Out of Reach" toolkit. New York, NY: The Partnership at Drugfree.org,

Annotation: This toolkit for health professionals and educators includes a 25-minute documentary about medicine abuse among adolescents, which is geared toward parents and other adults. Also available are supplemental materials, including (1) an introduction, which provides an overview of the documentary and instruction on how to hold a screening, invite people, and promote the screening; (2) a discussion guide; (3) action guides, which provide tips on how to talk about adolescent medicine abuse, how to recognize symptoms or medicine abuse, and how to talk to adolescents about this topic; (4) a resource sheet; (5) a sample invitation and poster; and (6) a press release and media advisory.

Contact: Partnership for Drug-Free Kids, 352 Park Avenue South, 9th Floor, New York, NY 10010, Telephone: (855) 378-4373 Secondary Telephone: (212) 922-1560 Fax: (212) 922-1570 E-mail: webmail@drugfree.org Web Site: http://www.drugfree.org/ Available from the website.

Keywords: Adolescent behavior, Marketing, Prescription drugs, Substance abuse, Symptoms

Fronstin P. 2013. Mental health, substance abuse, and pregnancy: Health spending following the PPACA adult-dependent mandate. Washington, DC: Employee Benefit Research Institute, 14 pp. (Issue brief)

Annotation: This issue brief examines the impact of adult-dependent mandate (ADM) from the experience of one large national employer on total spending, average spending, out-of-pocket costs, and use of health care services. The ADM requires group health plans that offer dependent coverage to provide coverage for adult children up to age 26. Information on the types of health care that enrolled young adults use as a result of the mandate and how these young adults may differ from already-enrolled individuals is provided. Topics include the impact of the ADM, study cohorts, spending, and prescription drugs.

Contact: Employee Benefit Research Institute, 1100 13th Street NW, Suite 878, Washington, DC 20005, Telephone: (202) 659-0670 Fax: (202) 775-6312 E-mail: info@ebri.org Web Site: http://www.ebri.org Available from the website.

Keywords: Access to health care, Costs, Health insurance, Health services, Legislation, Prescription drugs, Research, Young adults

National Education Association Health Information Network. 2013. Rx for understanding: Preventing prescription drug abuse–Educator's resource guide. Washington, DC: National Education Association Health Information Network, 104 pp.

Annotation: This standards-based, cross-curricular teaching resource is geared for students in grades 9-12. Contents include 10 lessons that lead students through an inquiry-based, technology inspired project enabling an opportunity to apply the key concepts learned about the misuse, abuse, and proper use of prescription drugs. The guide includes background information, lesson plans, a reproducible student journal, teaching resources, parent information, and national academic standards alignment charts (including National Health Education Standards and Common Core State Standards).

Contact: National Education Association Healthy Futures, 1201 16th Street, N.W., Suite 216, Washington, DC 20036-3290, Telephone: (202) 822-7570 Fax: (202) 822-7775 E-mail: info@neahealthyfutures.org Web Site: http://www.neahhealthyfutures.org Available from the website.

Keywords: Children, Injury prevention, Prescription drugs, Safety, School health education, Secondary schools, Substance abuse prevention, Teaching

National Education Association Health Information Network. [2012]. Rx for understanding: Be smart about prescription drugs–Educator's resource guide. Washington, DC: National Education Association Health Information Network, 120 pp.

Annotation: This standards-based, cross-curricular teaching resource is geared for students in grades 5-8. Contents include five sequenced lessons for grades 5-6 and five sequenced lessons for grades 7-8. Each set of lessons acts as a mini-unit, focusing on the same five lesson themes: relating the issue of prescription drug safety to overall health, understanding proper use, understanding misuse, understanding abuse, and conducting an application-based culminating project. The guide includes background information, lesson plans, reproducible student activity sheets, parent information, and national academic standards alignment charts (including National Health Education Standards and Common Core State Standards).

Contact: National Education Association Healthy Futures, 1201 16th Street, N.W., Suite 216, Washington, DC 20036-3290, Telephone: (202) 822-7570 Fax: (202) 822-7775 E-mail: info@neahealthyfutures.org Web Site: http://www.neahhealthyfutures.org Available from the website.

Keywords: Children, Injury prevention, Middle schools, Prescription drugs, Safety, School health education, Substance abuse prevention, Teaching

Pringle BA, Colpe LJ, Blumberg SJ, Avila RM, Kogan MD. 2012. Diagnostic history and treatment of school-aged children with autism spectrum disorder and special health care needs. Hyattsville, MD: National Center for Health Statistics, 7 pp. (NCHS data brief no. 97)

Annotation: This data brief provides information on diagnosis and treatment of school-age children and adolescents (ages 6-16) with special health care needs (CSHCN) and autism spectrum disorders (ASD). Topic include age of diagnosis, types of health professionals that identify CSHCN as having ASD, and health services and medications used by CSHCN with ASD.

Contact: National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Room 5419, Hyattsville, MD 20782, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 Fax: (301) 458-4020 E-mail: nchsquery@cdc.gov Web Site: http://www.cdc.gov/nchs Available from the website.

Keywords: Prescription drugs, Adolescents with special health care needs, Autism, Children with special health care needs, Diagnosis, Health services, Statistical data, Treatments

U.S. Government Accountability Office. 2012. Children's mental health: Concerns remain about appropriate services for children in Medicaid and foster care. Washington, DC: U.S. Government Accountability Office, 54 pp.

Annotation: This report, which focuses on child mental health services for children enrolled in Medicaid and in foster care, examines (1) the use of psychotropic medications and other mental health services for children enrolled in Medicaid nationwide, as well as other related Centers for Medicare & Medicaid Services initiatives; (2) Department of Health and Human Services (DHHS) information on the use of psychotropic medications and other mental health services for children in foster care nationwide, and related DHHS initiatives; and (3) the amount that DHHS has invested in research on children's mental health.

Contact: U.S. Government Accountability Office, 441 G Street, N.W., Washington, DC 20548, Telephone: (202) 512-3000 Secondary Telephone: E-mail: contact@gao.gov Web Site: http://www.gao.gov Available from the website.

Keywords: Access to health care, Children, Costs, Foster care, Initiatives, Medicaid, Mental health, Mental health services, Prescription drugs, Research

Institute of Medicine. 2011. Informing the future: Critical issues in health. (6th ed.). Washington, DC: National Academies Press, 196 pp.

Annotation: This document provides information about the work of the Institute of Medicine (IOM) in selected, major areas in recent years. The main sections illustrate work that IOM committees have done in several topic areas, including quality of care, pharmaceuticals, children and adolescents, public health, active-duty military and veterans, global health, health research, and clinical medicine. Following is a description of IOM's convening and collaborative activities -- those cases in which IOM has brought people together to share ideas and discuss possible solutions. The last section provides a comprehensive bibliography of IOM reports published since 2007.

Contact: National Academies Press, 500 Fifth Street, N.W., Keck 360, Washington, DC 20001, Telephone: (202) 334-3313 Secondary Telephone: (888) 624-8373 Fax: (202) 334-2451 E-mail: customer_service@nap.edu Web Site: http://www.nap.edu Available from the website after registration. Document Number: ISBN 0-309-21533-6.

Keywords: Adolescent health, Child health, International health, Military, Prescription drugs, Public health, Research

Bernstein J, Chollet D, Peterson S. 2010. How does insurance coverage improve health outcomes?. Princeton, NJ: Mathematica Policy Research, 5 pp. (Reforming health care: Issue brief, April 2010, no. 1)

Annotation: This brief looks at how insurance improves health outcomes by helping people obtain preventive and screening services, prescription drug benefits, and mental health and other services, as well as by improving continuity of care. Topics include health outcomes of the insured vs. the uninsured, the effects of lack of insurance, the importance of coverage features, and considerations for policymakers. The brief is the first in a series that highlights issues related to health care reform that policymakers may want to consider as they implement the federal health reform law.

Contact: Mathematica Policy Research, P.O. Box 2393, Princeton, NJ 08543-2393, Telephone: (609) 799-3535 Fax: (609) 799-0005 E-mail: info@mathematica-mpr.com Web Site: http://www.mathematica-mpr.com

Keywords: Costs, Health care reform, Health insurance, Health services, Mental health, Prescription drugs, Prevention, Public policy, Screening, Uninsured persons

Hughes D, Howell E, Trenholm C, Hill I, Dubay L. 2008. Three independent evaluations of Healthy Kids programs find dramatic gains in children's dental health care. Princeton, NJ: Mathematica Policy Research, 5 pp. (In brief, number 2)

Annotation: This brief presents highlights from independent evaluations of the Healthy Kids programs in three California counties—Los Angeles, San Mateo, and Santa Clara. These programs provide children from families with low incomes—but who are ineligible for California's two major state insurance programs—with comprehensive health-insurance coverage, including a broad range of medical, dental, and vision care; prescription drugs; and mental health services. The brief describes some of the positive impacts that Healthy Kids has had on children's access to and use of oral health services.

Contact: Mathematica Policy Research, P.O. Box 2393, Princeton, NJ 08543-2393, Telephone: (609) 799-3535 Fax: (609) 799-0005 E-mail: info@mathematica-mpr.com Web Site: http://www.mathematica-mpr.com Available from the website.

Keywords: Access to health care, California, Child health, Children, Families, Low income groups, Mental health, Oral health, Prescription drugs, State health insurance programs

Vanchieri C, Butler AS, Knutsen A. 2008. Addressing barriers to pediatric drug development: Workshop summary. Washington, DC: National Academies Press, 52 pp.

Annotation: This report summarizes presentations and discussions from the Institutes of Medicine workshop titled Addressing the Barriers to Pediatric Drug Development, held on June 13, 2006. The purpose of the workshop was to identify barriers to the development and testing of drugs for pediatric populations, as well as to examine ways in which the system can be improved to facilitate better treatments for children. Topics include the regulatory framework, models for enhancing pediatric drug development, and challenges and opportunities.

Contact: National Academies Press, 500 Fifth Street, N.W., Keck 360, Washington, DC 20001, Telephone: (202) 334-3313 Secondary Telephone: (888) 624-8373 Fax: (202) 334-2451 E-mail: customer_service@nap.edu Web Site: http://www.nap.edu Available from the website. Document Number: ISBN 0-309-10743-1.

Keywords: Child health, Development, Infant health, Prescription drugs, Regulations, Research

    Next Page »

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.